ABAnirban Banerjee

Anirban Banerjee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anirban Banerjee has a total of 141 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ZDHHC13 Is a Catalytically Deficient Protein S -Acyltransferase That Functions via a Noncanonical Mechanism

    by Andrey A. Petropavlovskiy, Alysha M. Church, Amelia H. Doerksen, Rahul Raina, Denver A. Bakhareva, Étienne P. Sellar, Nisandi N. Herath, Anirban Banerjee, Shaun S. Sanders

    S-Acylation is the addition of fatty acids to cysteine residues to regulate protein function and localization. S-Acylation is catalyzed by ZDHHC (Asp–His–His–Cys) protein S-acyltransferases (PATs), which S-acylate protein substrates by first auto-S-acylating the catalytic cysteine of the DHHC active site followed by transfer to the substrate. ZDHHC13 and ZDHHC17 are related ankyrin repeat domain (ANK) PATs that S-acylate neuronal proteins, including Huntingtin (HTT), the protein mutated in Huntington disease. However, unlike ZDHHC17 and other human PATs, ZDHHC13 possesses a noncanonical DQHC active site. As the first histidine is essential for auto-S-acylation, it is unclear if ZDHHC13 is catalytically active. Our phylogenetic analysis of eukaryotic ANK PATs showed that while the DHHC of ZDHHC17 orthologues is highly conserved, the motif is variable among ZDHHC13 orthologues, suggesting evolution independent of catalytic activity. We found that the ZDHHC13 catalytic cysteine is indeed S-acylated in cells, albeit substantially less than ZDHHC17 or ZDHHC20. We also confirmed minimal autoacylation activity in vitro with purified ZDHHC13. While wild-type (WT) ZDHHC13 increased S-acylation of an HTT1-588 fragment in cells, surprisingly, catalytically dead DQHS ZDHHC13 facilitated HTT1-588 S-acylation equally. This suggests that the ZDHHC13 catalytic cysteine is not required for substrate S-acylation and instead ZDHHC13 contributes to S-acylation via an indirect mechanism. Furthermore, ZDHHC13 was identified in a high-molecular-weight complex, suggesting a scaffolding or accessory role in S-acylation. This work broadens our understanding of this noncanonical PAT and lays the foundation for future mechanistic and structural studies.

  • Engineering NRas palmitoylation to hook zDHHC inhibitors

    by Mitra S. Rana, Anirban Banerjee

  • Palmitoyl Acyltransferases Control the Membrane Localization of DNAJC5 to Regulate Unconventional Protein Secretion

    by Yue Xu, Robbins Puthenveetil, Juhyung Lee, Layla Saidi, Anirban Banerjee, Yihong Ye

    Misfolded proteins lacking signal sequence can be secreted into the extracellular space via an unconventional protein secretion (UcPS) process termed misfolding‐associated protein secretion (MAPS), which involves HSP70 and a membrane‐associated HSP70 co‐chaperone named DNAJC5. Here, we show that DNAJC5 can be palmitoylated by several DHHC palmitoyl acyltransferases in human cells. Among them, DHHC11 has a modest activity toward DNAJC5, but its overexpression enriches DNAJC5 in a Golgi‐associated compartment, which correlates with increased secretion. Mutagenesis studies show that a minimum DNAJC5 module (DC95) consisting of the palmitoyl acceptor‐enriched cysteine string (CS) domain plus the C‐terminal 62 residues and a short upstream segment is sufficient to drive palmitoylation, Golgi translocation and secretion. In contrast, removal of 5 residues from DC95 abolishes its palmitoylation, Golgi association and secretion. These findings suggest that the palmitoylation sites of DNAJC5 act with flanking sequences to control its subcellular localization and UcPS function.


  • Enhanced S-Palmitoylated Protein Detection by Mild Nonionic Detergent in Proteomic Workflow

    by Hyojung Kim, Jiraphorn Issara-Amphorn, SungHwan Yoon, Anirban Banerjee, Aleksandra Nita-Lazar

    Loss of hydrophobic peptides and proteins remains a significant challenge in bottom-up proteomics, resulting in under-representation of membrane and membrane-associated proteins that are critical for understanding cellular function and disease. This limitation is particularly acute for targeted applications such as S-palmitoylation analysis, where modifications occur preferentially on membrane-proximal cysteines. This study evaluated supplementation by n-dodecyl-β-d-maltopyranoside (DDM), a mild detergent widely used in structural biology but not proteomics, during the postprecipitation resolubilization step to enhance hydrophobic protein recovery. Using immortalized bone marrow-derived macrophages (iBMDMs), we compared standard resolubilization (8 M urea in 50 mM ammonium bicarbonate) with DDM-supplemented conditions. In global proteomics, DDM supplementation improved peptide and protein identifications, with particularly pronounced benefits for membrane protein recovery. The 539 proteins uniquely identified with DDM were enriched for mitochondrial components, protein complexes, and membrane-bounded organelles. For acyl-biotin exchange (ABE) proteomics targeting palmitoylated proteins, DDM supplementation enhanced recovery of proteins, with 223 proteins consistently requiring DDM for identification. These DDM-dependent proteins showed enrichment for transport and localization functions characteristic of palmitoylated proteins. Comparison with the SwissPalm database revealed 336 previously unreported S-palmitoylation candidates, with DDM conditions contributing more novel identifications than urea alone. These findings demonstrate that DDM-assisted resolubilization addresses a key bottleneck in proteomics workflows, enabling more comprehensive characterization of hydrophobic and lipid-modified proteomes without requiring extensive protocol modifications.


  • Open Access

    In vitro reconstitution reveals substrate selectivity of protein S-acyltransferases

    by Tanmay Mondal, James Song, Anirban Banerjee


  • Open Access

    In vitro reconstitution of transition metal transporters

    by Elvis L. Ongey, Anirban Banerjee


  • Top Cited Papers

    ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D

    by Gang Du, Liam B. Healy, Liron David, Caitlin Walker, Tarick J. El-Baba, Corinne A. Lutomski, Byoungsook Goh, Bowen Gu, Xiong Pi, Pascal Devant, et al.

    Gasdermin D (GSDMD) is the common effector for cytokine secretion and pyroptosis downstream of inflammasome activation and was previously shown to form large transmembrane pores upon cleavage by inflammatory caspases to generate the GSDMD N-terminal domain (GSDMD-NT)1-10. Here we report that GSDMD Cys191 is S-palmitoylated and palmitoylation is required for pore formation. S-palmitoylation, which does not affect GSDMD cleavage, is augmented by mitochondria-generated reactive oxygen species (ROS). Surprisingly, cleavage-deficient D275A GSDMD is also palmitoylated after inflammasome stimulation or treatment with ROS activators, and causes pyroptosis, although less efficiently than palmitoylated GSDMD-NT. Palmitoylated, but not unpalmitoylated, full-length GSDMD induces liposome leakage, and forms a pore similar in structure to GSDMD-NT pores shown by cryogenic electron microscopy. zDHHC5 and zDHHC9 are the major palmitoyltransferases that mediate GSDMD palmitoylation, and their expression is upregulated by inflammasome activation and ROS. The other human gasdermins are also palmitoylated in their N-termini. These data challenge the concept that cleavage is the only trigger for GSDMD activation. They suggest that reversible palmitoylation is a checkpoint for pore formation by both GSDMD-NT and intact GSDMD that serves as a general switch for the activation of this pore-forming family.


  • Open Access

    Orthogonal Enzyme–Substrate Design Strategy for Discovery of Human Protein Palmitoyltransferase Substrates

    by Robbins Puthenveetil, Shelby A. Auger, Natalia Gómez-Navarro, Mitra Shumsher Rana, Riki Das, Liam Brendan Healy, Kiall F. Suazo, Zhen-Dan Shi, Rolf E. Swenson, Mark D. Distefano, et al.

    Protein palmitoylation, with more than 5000 substrates, is the most prevalent form of protein lipidation. Palmitoylated proteins participate in almost all areas of cellular physiology and have been linked to several human diseases. Twenty-three zDHHC enzymes catalyze protein palmitoylation with extensive overlap among the substrates of each zDHHC member. Currently, there is no global strategy to delineate the physiological substrates of individual zDHHC enzymes without perturbing the natural cellular pool. Here, we outline a general approach to accomplish this on the basis of synthetic orthogonal substrates that are only compatible with engineered zDHHC enzymes. We demonstrate the utility of this strategy by validating known substrates and use it to identify novel substrates of two human zDHHC enzymes. Finally, we employ this method to discover and explore conserved palmitoylation in a family of host restriction factors against pathogenic viruses, including SARS-CoV-2.


  • Architects of the membrane: structures of eukaryotic choline phosphotransferase 1 and choline/ethanolamine phosphotransferase 1

    by Rahul Raina, Anirban Banerjee

    New cryo-electron microscopy (cryo-EM) structures of CDP- and CDP-choline-bound choline phosphotransferase 1 (CHPT1) and choline/ethanolamine phosphotransferase 1 (CEPT1), involved in the metabolism of the two main lipids in eukaryotic cell membranes, capture the membrane proteins at resolution <4 Å, sufficient to gain mechanistic insights into these enzymes.